Cargando…
KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism
Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven pancreatic cancer is very lethal, with a five-year survival rate of <9%, irrespective of therapeutic advances. Different treatment modalities including chemotherapy, radiotherapy, and immunotherapy demonstrated only marginal efficacies beca...
Autores principales: | Muyinda, Isaac James, Park, Jae-Gwang, Jang, Eun-Jung, Yoo, Byong-Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150642/ https://www.ncbi.nlm.nih.gov/pubmed/34064761 http://dx.doi.org/10.3390/ijms22105070 |
Ejemplares similares
-
Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells
por: Hatipoglu, Ahmet, et al.
Publicado: (2022) -
Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway
por: Son, Jaekyoung, et al.
Publicado: (2013) -
Extra-mitochondrial citrate synthase initiates calcium oscillation and suppresses age-dependent sperm dysfunction
por: Kang, Woojin, et al.
Publicado: (2019) -
CRISPR prime editing for unconstrained correction of oncogenic KRAS variants
por: Jang, Gayoung, et al.
Publicado: (2023) -
Correction: Extra-mitochondrial citrate synthase initiates calcium oscillation and suppresses age-dependent sperm dysfunction
por: Kang, Woojin, et al.
Publicado: (2020)